Emeryville, CA, United States of America

Jeannie Hou


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):

Title: **Jeannie Hou: Innovator in Immunotherapy for Hepatocellular Carcinoma**

Introduction

Jeannie Hou is an accomplished inventor based in Emeryville, California. She has made significant contributions to the field of immunotherapy, particularly in the treatment of hepatocellular carcinoma, a common form of liver cancer. With a strong focus on innovations aimed at addressing critical health challenges, her work exemplifies the intersection of science and compassion.

Latest Patents

Jeannie Hou holds a patent for her groundbreaking work titled "Immunotherapy for Hepatocellular Carcinoma." This patent discloses a method for the prevention, delay of progression, or treatment of hepatocellular carcinoma. The method involves administering a therapeutically effective amount of an anti-PD-1 antibody, which specifically binds to human PD-1. This innovative approach holds the potential to significantly improve outcomes for patients diagnosed with this aggressive cancer.

Career Highlights

Jeannie currently works with BeiGene, Ltd., a biotechnology company known for its focus on developing innovative medicines for cancer treatment. Her dedication to research and development has positioned her as a leading figure in her field, showcasing her commitment to advancing therapeutic options for patients in need.

Collaborations

Throughout her career, Jeannie has collaborated with talented colleagues, including Lai Wang and Kang Li. These partnerships contribute to a dynamic research environment, fostering innovative solutions and enhancing the development of new therapies. Together, they work towards shared goals of improving healthcare outcomes and expanding treatment options for various diseases.

Conclusion

Jeannie Hou's contributions to the field of immunotherapy exemplify the impact of innovation on healthcare. Her pioneering patent for treating hepatocellular carcinoma highlights her commitment to improving patient care through scientific research and collaboration. As she continues her work with BeiGene, her advancements will undoubtedly play a crucial role in shaping the future of cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…